Photo of Connie Lehman,  MD, PhD

Connie Lehman, MD, PhD

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 724-3483


clehman@mgh.harvard.edu

Connie Lehman, MD, PhD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Professor, Radiology, Harvard Medical School
  • Chief of Breast Imaging, radiology, Massachusetts General Hospital
  • Co-director of AVON Breast Center, Radiology, Massachusetts General Hospital
  • Director, Breast Imaging Research Center, Radiology, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

As a change agent, innovator, and pioneer in the domain of Artificial Intelligence implementation in clinical medical practice, my work applies artificial intelligence and advanced methods of deep learning to improve breast cancer detection, diagnosis and treatment. In collaboration with colleagues at MIT, my lab and clinical center is applying AI to deliver higher quality health outcomes at lower costs for the full diversity of patients at risk for and with cancer. This is a continuation of my career-long commitment to expand access for all patients globally to highest quality, patient-centered, affordable care.

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Lehman CD, Mercaldo SF, Wang GX, Dontchos BN, Specht MC, Lamb LR. Screening Mammography Recovery After COVID-19 Pandemic Facility Closures: Associations of Facility Access and Racial and Ethnic Screening Disparities. AJR Am J Roentgenol 2022. PubMed
  • Kelly BN, Webster AJ, Lamb L, Spivey T, Korotkin JE, Henriquez A, Gadd MA, Hughes KS, Lehman CR, Smith BL, Specht MC. Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions. Clin Breast Cancer 2022. PubMed
  • Yala A, Mikhael PG, Strand F, Lin G, Satuluru S, Kim T, Banerjee I, Gichoya J, Trivedi H, Lehman CD, Hughes K, Sheedy DJ, Matthis LM, Karunakaran B, Hegarty KE, Sabino S, Silva TB, Evangelista MC, Caron RF, Souza B, Mauad EC, Patalon T, Handelman-Gotlib S, Guindy M, Barzilay R. Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model. J Clin Oncol 2021. PubMed
  • Fazeli S, Snyder BS, Gareen IF, Lehman CD, Khan SA, Romanoff J, Gatsonis CA, Miller KD, Sparano JA, Comstock CE, Wagner LI, Carlos RC. Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112). JAMA Netw Open 2021; 4:e2129697. PubMed
  • Yang K, Abbey CK, Chou SS, Dontchos BN, Li X, Lehman CD, Liu B. Power Spectrum Analysis of Breast Parenchyma with Digital Breast Tomosynthesis Images in a Longitudinal Screening Cohort from Two Vendors. Acad Radiol 2021. PubMed
  • Spilseth B, McKnight CD, Li MD, Park CJ, Fried JG, Yi PH, Brian JM, Lehman CD, Wang XJ, Phalke V, Pakkal M, Baruah D, Khine PP, Fajardo LL. AUR-RRA Review: Logistics of Academic-Industry Partnerships in Artificial Intelligence. Acad Radiol 2021. PubMed
  • Koh SB, Dontchos BN, Bossuyt V, Edmonds C, Cristea S, Melkonjan N, Mortensen L, Ma A, Beyerlin K, Denault E, Niehoff E, Hirz T, Sykes DB, Michor F, Specht M, Lehman C, Ellisen LW, Spring LM. Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses. NPJ Precis Oncol 2021; 5:85. PubMed
  • Dontchos BN, Achibiri J, Mercaldo SF, Wang GX, Lamb LR, Miles RC, Narayan AK, Lehman CD. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic. AJR Am J Roentgenol 2021. PubMed
  • McCarthy AM, Friebel-Klingner T, Ehsan S, He W, Welch M, Chen J, Kontos D, Domchek SM, Conant EF, Semine A, Hughes K, Bardia A, Lehman C, Armstrong K. Relationship of established risk factors with breast cancer subtypes. Cancer Med 2021; 10:6456-6467. PubMed
  • Haas JS, Atlas SJ, Wright A, Orav EJ, Aman DG, Breslau ES, Burdick TE, Carpenter E, Chang F, Dang T, Diamond CJ, Feldman S, Harris KA, Hort SJ, Housman ML, Mecker A, Lehman CD, Percac-Lima S, Smith R, Wint AJ, Yang J, Zhou L, Tosteson ANA. Multilevel follow-up of cancer screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test results. Contemp Clin Trials 2021; 109:106533. PubMed
  • Chou SS, Romanoff J, Lehman CD, Khan SA, Carlos R, Badve SS, Xiao J, Corsetti RL, Javid SH, Spell DW, Han LK, Sabol JL, Bumberry JR, Gareen IF, Snyder BS, Gatsonis C, Wagner LI, Wolff AC, Miller KD, Sparano JA, Comstock CE, Rahbar H. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Radiology 2021. PubMed
  • McCarthy AM, Ehsan S, Appel S, Welch M, He W, Bahl M, Chen J, Lehman CD, Armstrong K. Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram. Cancer 2021. PubMed
  • Lehman CD, D'Alessandro HA, Mendoza DP, Succi MD, Kambadakone A, Lamb LR. Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. J Am Coll Radiol 2021. PubMed
  • Lehman CD, Lamb LR, D'Alessandro HA. Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach. AJR Am J Roentgenol 2021. PubMed
  • Miles RC, Lehman CD. Artificial Intelligence for Image Interpretation: Point-The Radiologist's Potential Friend. AJR Am J Roentgenol 2021. PubMed
  • Bahl M, Mercaldo S, McCarthy AM, Lehman CD. Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis. Radiology 2021; 298:308-316. PubMed
  • Yala A, Mikhael PG, Strand F, Lin G, Smith K, Wan YL, Lamb L, Hughes K, Lehman C, Barzilay R. Toward robust mammography-based models for breast cancer risk. Sci Transl Med 2021. PubMed
  • Miles RC, Flores EJ, Lopez DB, Sohn YJ, Gillis EA, Lehman CD, Narayan AK. Leveraging Emergency Department Encounters to Improve Cancer Screening Adherence. J Am Coll Radiol 2021. PubMed
  • Onishi N, Li W, Newitt DC, Harnish RJ, Strand F, Nguyen AA, Arasu VA, Gibbs J, Jones EF, Wilmes LJ, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard S, Umphrey HR, Nelson MT, Church AL, Bolan PJ, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez Paniagua D, Hardesty L, Brandt KR, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane E, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica LA, Niell B, Drukteinis J, Newell MS, Giurescu ME, Berman E, Lehman CD, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau SH, Chenevert T, Yau C, DeMichele A, Berry DA, Esserman LJ, Hylton NM. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology 2021; 301:295-308. PubMed
  • Li W, Newitt DC, Gibbs J, Wilmes LJ, Jones EF, Arasu VA, Strand F, Onishi N, Nguyen AA, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard SA, Umphrey H, Bernreuter W, Nelson M, Church AL, Bolan P, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez-Paniagua D, Hardesty L, Brandt K, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane EP, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica A, Niell BL, Drukteinis J, Newell MS, Cohen MA, Giurescu M, Berman E, Lehman C, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau S, Chenevert T, Yau C, DeMichele A, Berry D, Esserman LJ, Hylton NM. Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL. NPJ Breast Cancer 2020; 6:63. PubMed
  • Narayan AK, Mercaldo SF, Gupta YP, Warner ET, Lehman CD, Miles RC. Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey. Breast Cancer Res Treat 2020. PubMed
  • Narayan AK, Lee CI, Lehman CD. Screening for Breast Cancer. Med Clin North Am 2020; 104:1007-1021. PubMed
  • Lamb LR, Oseni TO, Lehman CD, Bahl M. Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease? Eur J Radiol 2020; 129:109130. PubMed
  • Wang GX, Pizzi BT, Miles RC, Dontchos BN, LaPointe AP, Lehman CD, Narayan AK. Implementation and Utilization of a "Pink Card" Walk-In Screening Mammography Program Integrated With Physician Visits. J Am Coll Radiol 2020. PubMed
  • Sippo DA, Sullivan AM, Cohen A, Mercaldo SF, Bahl M, Lehman CD. The Adoption and Impact on Performance of an Automated Outcomes Feedback Application for Tomosynthesis Screening Mammography. J Am Coll Radiol 2020. PubMed
  • Kang J, Thompson RF, Aneja S, Lehman C, Trister A, Zou J, Obcemea C, El Naqa I. NCI Workshop on Artificial Intelligence in Radiation Oncology: Training the Next Generation. 2020. PubMed
  • Bahl M, Mercaldo S, Dang PA, McCarthy AM, Lowry KP, Lehman CD. Breast Cancer Screening with Digital Breast Tomosynthesis: Are Initial Benefits Sustained? Radiology 2020; 295:529-539. PubMed
  • Panigrahi B, Miles RC, Chou SS, Brackett DG, Sohn YJ, Lehman C. Rare case of invasive lobular carcinoma in a male. Radiol Case Rep 2020; 15:727-729. PubMed
  • Kuhl CK, Lehman C, Bedrosian I. Imaging in Locoregional Management of Breast Cancer. J Clin Oncol 2020. PubMed
  • Oseni TO, Smith BL, Lehman CD, Vijapura CA, Pinnamaneni N, Bahl M. Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma? Ann Surg Oncol 2020. PubMed
  • Isakoff SJ, Lehman CD, Shannon KM, Basnet KM. Case 7-2020: A 52-Year-Old Man with a Mass in the Left Breast. N Engl J Med 2020; 382:856-864. PubMed
  • Dontchos BN, Yala A, Barzilay R, Xiang J, Lehman CD. External Validation of a Deep Learning Model for Predicting Mammographic Breast Density in Routine Clinical Practice. Acad Radiol 2020. PubMed
  • Narayan AK, Lehman CD. Mammography Screening Guideline Controversies: Opportunities to Improve Patient Engagement in Screening. J Am Coll Radiol 2020. PubMed
  • Debruhl ND, Lee SJ, Mahoney MC, Hanna L, Tuite C, Gatsonis CA, Lehman C. MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-up. J Breast Imaging 2020; 2:50-55. PubMed
  • Wang GX, Narayan AK, Park ER, Lehman CD, Gorenstein JT, Flores EJ. Screening Mammography Visits as Opportunities to Engage Smokers With Tobacco Cessation Services and Lung Cancer Screening. J Am Coll Radiol 2020. PubMed
  • Lamb LR, Gilman L, Specht M, D'Alessandro HA, Miles R, Lehman CD. Retrospective Review of Pre-operative Radiofrequency Tag Localization of Breast Lesions in 848 Patients. AJR Am J Roentgenol 2020. PubMed
  • Lopez D, Miles RC, Flores EJ, Lehman CD, Narayan AK. Breast Cancer Screening in Puerto Rico and Other US Territories: Findings from the 2016 Behavioral Risk Factor Surveillance System Survey. J Health Care Poor Underserved 2020; 31:340-352. PubMed
  • Miles RC, Choi P, Baird GL, Dibble EH, Lamb L, Garg M, Lehman C. Will the Effect of New Federal Breast Density Legislation Be Diminished by Currently Available Online Patient Educational Materials? Acad Radiol 2019. PubMed
  • Edmonds CE, Lamb LR, Mercaldo SF, Sippo DA, Burk KS, Lehman CD. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI. AJR Am J Roentgenol 2019. PubMed
  • Lamb LR, Lehman CD, Oseni TO, Bahl M. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma. Acad Radiol 2019. PubMed
  • Yala A, Schuster T, Miles R, Barzilay R, Lehman C. A Deep Learning Model to Triage Screening Mammograms: A Simulation Study. Radiology 2019; 293:38-46. PubMed
  • Dontchos BN, Rahbar H, Partridge SC, Lehman CD, DeMartini WB. Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women. J Breast Imaging 2019; 1:205-211. PubMed
  • Miles RC, Lehman CD, Mercaldo SF, Tamimi RM, Dontchos BN, Narayan AK. Obesity and breast cancer screening: Cross-sectional survey results from the behavioral risk factor surveillance system. Cancer 2019. PubMed
  • Sippo DA, Rutledge GM, Mercaldo SF, Burk KS, Edmonds CE, Dang PA, Lehman CD. Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI. Acad Radiol 2019. PubMed
  • Lam DL, Smith J, Partridge SC, Kim A, Javid SH, Hippe DS, Lehman CD, Lee JM, Rahbar H. The Impact of Preoperative Breast MRI on Surgical Management of Women with Newly Diagnosed Ductal Carcinoma In Situ. Acad Radiol 2019. PubMed
  • Flores EJ, López D, Miles RC, Glover M, Lehman CD, Harvey HB, Narayan AK. Impact of Primary Care Physician Interaction on Longitudinal Adherence to Screening Mammography Across Different Racial/Ethnic Groups. J Am Coll Radiol 2019; 16:908-914. PubMed
  • Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R. A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction. Radiology 2019; 292:60-66. PubMed
  • Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage. Acad Radiol 2019; 26:726-731. PubMed
  • Dontchos BN, Narayan AK, Seidler M, Mercaldo SF, Miles RC, Ebert E, Lehman CD. Impact of a Same-Day Breast Biopsy Program on Disparities in Time to Biopsy. J Am Coll Radiol 2019. PubMed
  • Choudhery S, Chou SS, Chang K, Kalpathy-Cramer J, Lehman CD. Kinetic Analysis of Lesions Identified on a Rapid Abridged Multiphase (RAMP) Breast MRI Protocol. Acad Radiol 2019. PubMed
  • López D, Flores EJ, Miles RC, Wang G, Glover M, Shepard JA, Lehman CD, Narayan AK. Assessing Eligibility for Lung Cancer Screening Among Women Undergoing Screening Mammography: Cross-Sectional Survey Results From the National Health Interview Survey. J Am Coll Radiol 2019. PubMed
  • Bahl M, Lehman CD. Breast Cancer Screening Using Digital Breast Tomosynthesis: Not All Mammography Is Equal. JAMA Oncol 2019; 5:642-643. PubMed
  • Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk. JAMA Intern Med 2019; 179:658-667. PubMed
  • Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. J Clin Oncol 2019; 37:954-963. PubMed
  • Portnoi T, Yala A, Schuster T, Barzilay R, Dontchos B, Lamb L, Lehman C. Deep Learning Model to Assess Cancer Risk on the Basis of a Breast MR Image Alone. AJR Am J Roentgenol 2019. PubMed
  • Narayan AK, Lopez DB, Miles RC, Dontchos B, Flores EJ, Glover M, Lehman CD. Implementation of an Intimate Partner Violence Screening Assessment and Referral System in an Academic Women's Imaging Department. J Am Coll Radiol 2019; 16:631-634. PubMed
  • Sippo DA, Rutledge GM, Burk KS, Mercaldo SF, Dontchos BN, Edmonds CE, Lehman CD. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI. AJR Am J Roentgenol 2019. PubMed
  • Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC. Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin Cancer Res 2019; 25:1756-1765. PubMed
  • Cui C, Chou SS, Brattain L, Lehman CD, Samir AE. Data Engineering for Machine Learning in Women's Imaging and Beyond. AJR Am J Roentgenol 2019. PubMed
  • Bahl M, Maunglay M, D'Alessandro HA, Lehman CD. Comparison of Upright Digital Breast Tomosynthesis-guided versus Prone Stereotactic Vacuum-assisted Breast Biopsy. Radiology 2019; 290:298-304. PubMed
  • Roark AA, Dang PA, Niell BL, Halpern EF, Lehman CD. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer. AJR Am J Roentgenol 2019; 212:271-279. PubMed
  • Lehman CD, Gatsonis C, Romanoff J, Khan SA, Carlos R, Solin LJ, Badve S, McCaskill-Stevens W, Corsetti RL, Rahbar H, Spell DW, Blankstein KB, Han LK, Sabol JL, Bumberry JR, Gareen I, Snyder BS, Wagner LI, Miller KD, Sparano JA, Comstock C. Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment. JAMA Oncol 2019. PubMed
  • Lehman CD, Yala A, Schuster T, Dontchos B, Bahl M, Swanson K, Barzilay R. Mammographic Breast Density Assessment Using Deep Learning: Clinical Implementation. Radiology 2019; 290:52-58. PubMed
  • Miles RC, Narayan AK, Lopez DB, Lehman CD, Harvey HB, Mishra V, Glover M, Flores EJ. Chronic Medical Illness as a Risk Factor for Poor Mammography Screening Adherence. J Womens Health (Larchmt) 2018. PubMed
  • Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA. Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr 2018; 2:pky063. PubMed
  • Narayan AK, Elkin EB, Lehman CD, Morris EA. Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines. Breast Cancer Res Treat 2018; 172:463-468. PubMed
  • Narayan AK, Flores EJ, Harvey HB, Lehman CD. Population-Based Health Engagement Opportunities Through Breast Imaging: A Population-Based Cross-Sectional Survey. J Am Coll Radiol 2018; 15:1401-1407. PubMed
  • Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM, . MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol 2018; 210:1376-1385. PubMed
  • Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol 2018; 36:2070-2077. PubMed
  • Scheel JR, Molina Y, Anderson BO, Patrick DL, Nakigudde G, Gralow JR, Lehman CD, Thompson B. Breast Cancer Beliefs as Potential Targets for Breast Cancer Awareness Efforts to Decrease Late-Stage Presentation in Uganda. J Glob Oncol 2018; 4:1-9. PubMed
  • Scheel JR, Molina Y, Patrick DL, Anderson BO, Nakigudde G, Lehman CD, Thompson B. Breast Cancer Downstaging Practices and Breast Health Messaging Preferences Among a Community Sample of Urban and Rural Ugandan Women. J Glob Oncol 2017; 3:105-113. PubMed
  • Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD, . National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology 2017; 283:59-69. PubMed
  • Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM, . MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. J Magn Reson Imaging 2017; 46:290-302. PubMed
  • Scheel JR, Molina Y, Coronado G, Bishop S, Doty S, Jimenez R, Thompson B, Lehman CD, Beresford SA. Healthcare Factors for Obtaining a Mammogram in Latinas With a Variable Mammography History. Oncol Nurs Forum 2017; 44:66-76. PubMed
  • Luo J, Johnston BS, Kitsch AE, Hippe DS, Korde LA, Javid S, Lee JM, Peacock S, Lehman CD, Partridge SC, Rahbar H. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment. Radiology 2017; 285:788-797. PubMed
  • Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology 2017; 283:49-58. PubMed
  • Lee JM, Miglioretti DL, Burnside ES, Morris EA, Smith RA, Lehman CD. Mammography Performance Benchmarks in an Era of Value-based Care. Radiology 2017; 284:605-607. PubMed
  • Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology 2017; 285:44-52. PubMed
  • Lee JM, Partridge SC, Liao GJ, Hippe DS, Kim AE, Lee CI, Rahbar H, Scheel JR, Lehman CD. Double reading of automated breast ultrasound with digital mammography or digital breast tomosynthesis for breast cancer screening. Clin Imaging ; 55:119-125. PubMed
Hide